Merck & Co Inc
NYSE: MRK
$100.09
+$0.44 (+0.4%)
Closing Price on January 15, 2025
MRK Articles
You know it’s a rough day in the market when even defensive stocks are weak or mixed. We are at least seeing a mixed bag from some of these. But the trend is a pretty easy one to see. Even...
Published:
According to Reuters, Lehman (LEH) will release earnings a week early after its stock dropped 45%. Reuters reports that OPEC agreed to a surprise production cut. Reuters reports that CFOs are more...
Published:
Last Updated:
The evidence that sales at many companies are struggling and that employment will suffer are almost everywhere. Recently, a division of GMAC said it would let 5,000 people go. According to MSNBC,...
Published:
Last Updated:
Merck (MRK) and Schering-Plough (SGP) make two of the most widely sold drugs in the world. One is cholesterol drug Zetia. Another is a related drug called Vytorin. The sales of the treatments topped...
Published:
Last Updated:
Texas Instruments (TXN) Bad earnings take chip company down. Falls to $23.28 from 52-week high of $38.79. AMD (AMD) Chip company may have changed CEOs but Wall St. still thinks company is dead. Sells...
Published:
Last Updated:
According to Reuters, Apple (AAPL) missed Wall St. expectations, sending the stock down by 10%. Reuters reports that American Express (AXP) profits fell on credit losses.
Published:
Last Updated:
Merck & Co. (NYSE: MRK) posted earnings that look pretty good on the surface. The problem is that the surface is about the only thing that looked appealing for the drug giant today. Merck...
Published:
Last Updated:
These are not all of the upgrades or positive analyst calls seen this morning but these are some of the top calls seen this Friday morning: Aventine Renewable (NYSE: AVR) Raised to Buy from Neutral...
Published:
According to Reuters, Robert Steel was named the new CEO of Wachovia (WB) and the bank said it would have a quarter loss of $2.6 to $2.8 billion. Reuters writes that the Blue Chip Economic Indicators...
Published:
We have run a full feature story over at BioHealthInvestor.com after reading a study that came off the Mayo Clinic site. The study showed that a combination of fish oil and red rice yeast in...
Published:
According to Reuters, Microsoft (MSFT) is willing to start buy-out talks with Yahoo! (YHOO) if the portal company will replace its board. Reuters writes that the CEO of JP Morgan (JPM) said the SEC...
Published:
These are ten of the analyst calls with upgrades and downgrades we are focusing on this Monday morning in pre-market trading: Acme Packet (NASDAQ: APKT) cut to Underweight at JPMorgan; cut to Neutral...
Published:
We saw another exciting week full of news for key developments in drug stocks, biotech stocks, medical device stocks, and other companies involved in various aspects of health care and medicine. ...
Published:
It used to be that DEFENSIVE STOCKS were the way to go during periods of uncertainty and during times of market sell-offs. But now that isn’t even working out. After we looked at our first line...
Published:
Today’s 52-week low list was full of some of the usual suspects, and you can count airlines as the top group of 52-week lows after that breather in oil prices did not hold. There were also many...
Published:
Last Updated:
Our expert who first called NVIDIA in 2009 is predicting 2025 will see a historic AI breakthrough.
You can follow him investing $500,000 of his own money on our top AI stocks for free.